This is the third in a series of articles relating results from a line of research whose intent was to construct a complete history of patient interactions with the health care system using available data sources for all patients diagnosed in 1990 with a primary breast, colorectal, or lung tumour in Manitoba. This article presents details of the development and application of methods to produce TNM staging data on the roughly 2,000 patients in this population. The operational definitions constructed for this research can be adapted for other tumour sites and data sources. Findings include methods developed to overcome the sometimes ambiguous and inconsistent available documentation, which ultimately produced reliable TNM staging data. Survi...
The correct staging of disease, with an exact definition of the extent of cancer at the diagnosis, i...
Lung cancer remains the most common cause of cancer-related mortality in Scotland, accounting for 28...
The International Cancer Benchmarking Partnership is investigating cancer survival differences betwe...
This is the first in a series of articles relating results from research which constructed a complet...
This is the second in a series of articles from a line of research whose intent was to construct a c...
The staging of tumors according to the "TNM" system was developed by P Denoix between 1943 and 1952....
The staging of tumors according to the 'TNM' system was developed by P Denoix between 1943 and 1952....
Five decades ago, Denoix et al. proposed classification system (tumor node metastasis [TNM]) based o...
Background: Stage at diagnosis is a strong predictor of cancer survival. Differences in stage distri...
The tumor, node, metastasis system for cancer staging evolved in the middle of the last century. It ...
Staging systems aim to describe malignant tumours in a standardized fashion to assist in therapy pla...
The Tumour, Node, Metastasis (TNM) system for classifying lung cancer is the cornerstone of modern l...
SummaryLung cancer remains the most common cause of cancer-related mortality in Scotland, accounting...
Background: There is neither a nation-wide nor a large-scale , multi- institutional lung cancer data...
The correct staging of disease, with an exact definition of the extent of cancer at the diagnosis, i...
The correct staging of disease, with an exact definition of the extent of cancer at the diagnosis, i...
Lung cancer remains the most common cause of cancer-related mortality in Scotland, accounting for 28...
The International Cancer Benchmarking Partnership is investigating cancer survival differences betwe...
This is the first in a series of articles relating results from research which constructed a complet...
This is the second in a series of articles from a line of research whose intent was to construct a c...
The staging of tumors according to the "TNM" system was developed by P Denoix between 1943 and 1952....
The staging of tumors according to the 'TNM' system was developed by P Denoix between 1943 and 1952....
Five decades ago, Denoix et al. proposed classification system (tumor node metastasis [TNM]) based o...
Background: Stage at diagnosis is a strong predictor of cancer survival. Differences in stage distri...
The tumor, node, metastasis system for cancer staging evolved in the middle of the last century. It ...
Staging systems aim to describe malignant tumours in a standardized fashion to assist in therapy pla...
The Tumour, Node, Metastasis (TNM) system for classifying lung cancer is the cornerstone of modern l...
SummaryLung cancer remains the most common cause of cancer-related mortality in Scotland, accounting...
Background: There is neither a nation-wide nor a large-scale , multi- institutional lung cancer data...
The correct staging of disease, with an exact definition of the extent of cancer at the diagnosis, i...
The correct staging of disease, with an exact definition of the extent of cancer at the diagnosis, i...
Lung cancer remains the most common cause of cancer-related mortality in Scotland, accounting for 28...
The International Cancer Benchmarking Partnership is investigating cancer survival differences betwe...